Clinical Trial Update: A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating ALLO-ASC-DFU for deep second-degree burn wounds has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• ALLO-ASC-DFU

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Burn | Phase 1 | Status: COMPLETED